| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/06/1992 | WO1992001798A1 Srb1 encoding gene and yeasts transformed with this gene |
| 02/06/1992 | WO1992001796A1 Mycobacterial expression vector |
| 02/06/1992 | WO1992001794A2 Ancrod-like proteins, their preparation and their use |
| 02/06/1992 | WO1992001793A1 Cloning and expression of xylanase genes from fungal origin |
| 02/06/1992 | WO1992001791A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 02/06/1992 | WO1992001789A1 Stable and bioactive modified somatotropins |
| 02/06/1992 | WO1992001788A1 Beta chain of the human gm-csf receptor and uses thereof |
| 02/06/1992 | WO1992001783A1 Dna capable of site-specific integration into mycobacteria |
| 02/06/1992 | WO1992001782A2 Sucrose phosphate synthetase (sps), a preparation method and cdna therefor, and use of the cdna for modifying sps expression in plant cells |
| 02/06/1992 | WO1992001718A2 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 02/06/1992 | WO1992001717A1 Bacterial stress proteins |
| 02/06/1992 | WO1992001716A1 Protease resistant pdgf and methods of use |
| 02/06/1992 | WO1992001714A1 Non-a non-b hepatitis virus antigen |
| 02/06/1992 | WO1992001713A1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 02/06/1992 | WO1992001707A1 Purification directed cloning of peptides |
| 02/06/1992 | WO1992001705A1 Plasmodium vivax and plasmodium knowlesi duffy receptor |
| 02/06/1992 | WO1992001699A1 Pt-CONTAINING COMPOUND, PROCESS FOR ITS PREPARATION, AND APPLICATION OF SUCH COMPOUNDS |
| 02/06/1992 | WO1992001471A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | WO1992001460A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/06/1992 | DE4124537A1 New DNA sequence increasing gene expression in plant cells - is fragment of maize sucrose synthase gene, effective in mono- and dicotyledons |
| 02/06/1992 | DE4024187A1 Mutagenesis of plasmids in form of gapped circles - by hybridisation with mutagenic oligo:nucleotide, then selective linearisation of non-mutated circles |
| 02/06/1992 | CA2087982A1 Competitive pcr for quantitation of dna |
| 02/06/1992 | CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | CA2087160A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/06/1992 | CA2067329A1 Cloning and expression of xylanase genes from fungal origin |
| 02/05/1992 | EP0469919A2 A process for the enzymatic preparation of 7-aminocephalosporanic acid |
| 02/05/1992 | EP0469897A2 Engineered antibodies |
| 02/05/1992 | EP0469810A1 Plant acetyl-coa carboxylase polypeptide and gene |
| 02/05/1992 | EP0469755A1 Method producing a polynucleotide for use in single primer amplification |
| 02/05/1992 | EP0469632A1 Modulated xenogeneic organ systems in a immunocompromised host |
| 02/05/1992 | EP0469610A1 Improved two-step PCR method |
| 02/05/1992 | EP0469523A2 Cloning and overexpression of glucose-6-phosphate dehydrogenase of Leuconostoc dextranicus |
| 02/05/1992 | EP0469359A2 Method and product for the treatment of gastric disease |
| 02/05/1992 | EP0469348A2 cDNA sequence and detection of hepatits C virus |
| 02/05/1992 | EP0469281A1 Amino acid residue sequence of hepatitis B core antigen |
| 02/05/1992 | EP0469273A1 Fertile transgenic maize plants with foreign gene as well as method for their production |
| 02/05/1992 | EP0469089A1 Generation of hybrid genes and proteins by virus-mediated recombination |
| 02/05/1992 | EP0469080A1 Method of inhibiting induction of latent or chronic viral infections |
| 02/05/1992 | EP0469025A1 Improvements in or relating to enhancers. |
| 02/05/1992 | EP0469021A1 Determination of factors affecting gene regulation and/or gene replication. |
| 02/04/1992 | WO1992005252A1 STABLE PROPAGATION OF MODIFIED FULL LENGTH CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN cDNA IN HETEROLOGOUS SYSTEMS |
| 02/04/1992 | WO1992002619A1 Plasmid for use in producing inflamed region derived phospholipase a2 inhibitory protein, microbial cell, and production and use of said protein |
| 02/04/1992 | WO1992002534A2 Compounds and methods for inhibiting gene expression |
| 02/04/1992 | US5086169 Dna sequence for hybridizatin by gene expression |
| 02/04/1992 | US5085999 Method, apparatus, and reactant for removal of paint and epoxies from metallic beverage containers using microorganisms |
| 02/04/1992 | US5085983 Detection of human tumor progression and drug resistance |
| 02/04/1992 | US5085862 Mutants, vaccine; immunoprotective in mice |
| 02/04/1992 | US5085588 Transforming bacteria with a structural gene encoding the polypeptide, infecting a root of the plant host with the transformed bacteria, and growing the host to produce the |
| 02/04/1992 | CA2088673A1 Compounds and methods for inhibiting gene expression |
| 02/04/1992 | CA2067237A1 Plasmid and microbial cell for production of an inhibitory protein for phospholipase a2 from inflammatory sites, and the production and use of said protein |
| 02/04/1992 | CA2048406A1 Modulated xenogeneic organ systems in an immunocompromised host |
| 02/04/1992 | CA2048359A1 Dna sequences which impart resistance to the fungicide 8-chloro-4-(2-chloro-4-fluorophenoxy) quinoline |
| 02/04/1992 | CA1295271C Murine hybridoma and diagnostic antibody produced thereby |
| 02/04/1992 | CA1295270C Microbial degradation of hydrocarbons |
| 02/04/1992 | CA1295269C Polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon |
| 02/04/1992 | CA1295242C FORMULATIONS SUITABLE FOR THE STABILISATION OF .alpha.-INTERFERON |
| 02/03/1992 | WO1992002628A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | WO1992002251A1 Herpes simplex virus vp16 vaccines |
| 02/03/1992 | CA2088599A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | CA2066174A1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 02/02/1992 | WO1992002614A1 Novel thermostable pullulanases |
| 02/02/1992 | WO1992002540A1 Method for purifying a protein present in an inclusion body |
| 02/02/1992 | CA2088592A1 Thermostable pullulanases |
| 02/02/1992 | CA2066598A1 Process for the purification of a protein in inclusion bodies |
| 02/01/1992 | CA2048029A1 Amino acid residue sequence of hepatitis b core antigen |
| 02/01/1992 | CA2022356A1 Method and materials for producing proteins |
| 01/31/1992 | CA2048040A1 Plant acetyl-coa carboxylase polypetide and gene |
| 01/31/1992 | CA2045838A1 Cloning and overexpression of glucose-6-phosphate dehydrogenase from leuconostoc dextranicus |
| 01/30/1992 | DE4107765A1 Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt Pancreatic elastase-1-specific antibodies, a process for its production and to a test kit which such antibody contains |
| 01/30/1992 | DE4023945A1 Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikoerpern A process for purification of cytokeratin 20 and its use for the production of antibodies |
| 01/30/1992 | DE4023721A1 Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s) |
| 01/30/1992 | DE4023699A1 Neue proteine, ihre herstellung und verwendung New proteins, their production and use |
| 01/29/1992 | WO1992002630A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies |
| 01/29/1992 | EP0468812A2 Gene of candida yeast |
| 01/29/1992 | EP0468657A2 Non-A non B hepatitis-specific antigen and its use in hepatitus diagnosis |
| 01/29/1992 | EP0468637A1 In vivo targeting with bifunctional antibodies |
| 01/29/1992 | EP0468601A1 Methods and materials for HIV detection and therapy |
| 01/29/1992 | EP0468596A1 Enzymatic treatment of silage |
| 01/29/1992 | EP0468539A1 Hirudin derivatives |
| 01/29/1992 | EP0468464A2 Cellulase, method for producing the same and use thereof |
| 01/29/1992 | EP0468393A1 Process for the extraction and purification of human recombinant gamma interferon |
| 01/29/1992 | EP0468337A1 DNA coding for a human vasoconstrictive peptide and use thereof |
| 01/29/1992 | EP0468257A1 Multimeric form of human rhinovirus receptor protein |
| 01/29/1992 | EP0468220A2 Cloning of the biosynthetic pathway genes for chlortetracycline production from streptomyces aureofaciens & their expression in steptomyces lividans |
| 01/29/1992 | EP0468217A2 A bifunctional cosmid useful for cloning actinomycete DNA |
| 01/29/1992 | EP0468049A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen |
| 01/29/1992 | EP0467987A1 Methods and materials for expression of human plasminogen in a eukaryotic cell system |
| 01/29/1992 | EP0467972A1 Rickettsial antigens for vaccination and diagnosis |
| 01/29/1992 | EP0467965A1 Plasmodium circumsporozoite protein analogs lacking repeat sequences |
| 01/29/1992 | EP0467953A1 Improved primer extension reactions |
| 01/29/1992 | EP0467932A1 Urokinase-type plasminogen activator receptor |
| 01/29/1992 | EP0467883A1 Method of physically mapping genetic material |
| 01/28/1992 | WO1992002634A1 ASSAY, METHODS AND PRODUCTS BASED ON n K+ CHANNEL EXPRESSION |
| 01/28/1992 | WO1992002528A1 Incorporation of selectably clevable and/or abasic sites into oligonucleotide chains and reagents therefor |
| 01/28/1992 | US5084559 Protein a domain mutants |
| 01/28/1992 | US5084385 Process for producing alcohol using yeast transformed by rhizopus glucoamylase gene |
| 01/28/1992 | US5084384 Secretion of insulin-like growth factor-I |
| 01/28/1992 | US5084383 Producing a protein by linking, 5' to 3', and a promoter, a sequencer coding for a peptide, genetic engineering, cultures |
| 01/28/1992 | CA2088257A1 Incorporation of selectably clevable and/or abasic sites into oligonucleotide chains and reagents therefor |
| 01/28/1992 | CA2087268A1 Assay, methods and products based on nk+ channel expression |